切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (03) : 313 -316. doi: 10.3877/cma.j.issn.1674-6902.2017.03.015

所属专题: 文献

论著

脉冲振荡肺功能测定在稳定期慢性阻塞性肺疾病治疗中的应用价值
孟丹1,(), 张晓燕1, 朱健武1, 周波1, 杨蓉1, 陈秋霞1   
  1. 1. 519020 珠海,广东省珠海市第二人民医院呼吸内科
  • 收稿日期:2016-10-26 出版日期:2017-06-20
  • 通信作者: 孟丹
  • 基金资助:
    珠海市科技计划医疗卫生基金项目(一般项目)(20161027E030022)

Appling value of impulse oscillometry in patients with chronic obstructive pulmonary disease in stable stage

Dan Meng1,(), Xiaoyan Zhang1, Jianwu Zhu1, Bo Zhou1, Rong Yang1, Qiuxia Chen1   

  1. 1. Department of Respiratory Medicine, Zhuhai Second People′s Hospital, Zhuhai 519020, China
  • Received:2016-10-26 Published:2017-06-20
  • Corresponding author: Dan Meng
  • About author:
    Corresponding author: Meng Dan, Email:
引用本文:

孟丹, 张晓燕, 朱健武, 周波, 杨蓉, 陈秋霞. 脉冲振荡肺功能测定在稳定期慢性阻塞性肺疾病治疗中的应用价值[J]. 中华肺部疾病杂志(电子版), 2017, 10(03): 313-316.

Dan Meng, Xiaoyan Zhang, Jianwu Zhu, Bo Zhou, Rong Yang, Qiuxia Chen. Appling value of impulse oscillometry in patients with chronic obstructive pulmonary disease in stable stage[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(03): 313-316.

目的

探讨脉冲振荡肺功能测定(IOS)在稳定期慢性阻塞性肺疾病(COPD)临床治疗中的应用价值,及与传统肺功能检测的相关性。

方法

收集2013年1月至2015年12月我院呼吸科住院的稳定期COPD患者100例作为实验组,根据COPD严重程度分为A、B、C、D四组,A组(轻度)17例,B组(中度)21例,C组(重度)33例,D组(极重度)29例,另选40例健康人作为对照组。所有研究对象入组后进行IOS肺功能测定(ZrsFresR5、R20、X5)和传统肺功能测定(FEV1、FEV1/FVC),COPD患者治疗三个月后复诊。

结果

治疗前后,实验各组与健康组比较,FEV1、FEV1/FVC、X5显著降低,ZrsFresR5、R5-R20、R20显著升高;并且COPD越严重ZrsFresR5、R5-R20、R20越高,FEV1、FEV1/FVC、X5越低(P<0. 05);经过治疗后,四个实验组FEV1、FEV1/FVC显著升高,ZrsFresR5、R5-R20显著降低(P<0.05),X5、R20无明显改变。FEV1、FEV1/FVC与ZrsFresR5 、R5-R20呈明显负相关(P<0.05),与X5呈明显正相关(P<0.05),其中FEV1与Fres的相关性最强(r=-0.765)。

结论

IOS肺功能检测指标能客观反映气道阻力,并且与传统肺功能指标有良好的相关性,可以作为一种新的COPD诊断技术在临床上推广使用。

Objective

To research the application value of impulse oscillometry (IOS) in patients with chronic obstructive pulmonary disease (COPD) and its correlation with conventional detecting lung function indexes.

Methods

332 cases of COPD in our hospital from January 2013 to December 2015 were selected as experimental group, these patients were divided into mild 17 cases(group A), moderate 21 cases(group B), severe 33 cases(group C), very severe 29 cases(group D). 40 health people were selected as control group. The conventional lung function indicators (FEV1/FVC, FEV1) and IOS indexes (ZRS, Fres, R5, X5, R20) were detected before and after treatment and the correlation between them were also analyzed.

Results

The FEV1, FEV1/FVC and X5 of COPD patients were significantly lower than those of the control group, the indicators such as Zrs, Fres, R5, R5-R20 and R20 in experimenta group were significantly higher than in control group, these indicators worse with the development of disease. FEV1/FVC, FEV1, Zrs, Fres, R5 and R5-R20 obviously improved after treatment, and the difference was statistically significant (P<0.05). FEV1, FEV1/FVC had a negative correlation with Zrs, Fres, R5 and R5-R20 (P<0.05), but a positive correlation with X5 (P<0.05), the closest correlation was found in FEV1 and Fres(r=-0.765).

Conclusion

IOS and reflect the airway resistance and have a good correlation with the traditional lung function indexes. IOS can be used as a new detection technology in COPD patients.

表1 实验组与健康组治疗前各项指标对比(±s)
表2 实验组与健康组治疗后各项指标对比(±s)
表3 传统肺功能指标和IOS指标相关性分析r(P)
1
任成山,钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志(电子版), 2009, 2(2): 104-115.
2
Lopes AJ, Mafort TT. Correlations between small airway function, ventilation distribution, and functional exercise capacity in COPD patients[J]. Lung, 2014, 192(5): 653-659.
3
Yoshimoto D, Nakano Y, Onishi K, et al. The relationship between the COPD assessment test score and airflow limitation in Japan in patients aged over 40 years with a smoking history[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 1357-1363.
4
Yildiz F, Bingol KG, Ersu HR, et al. The evaluation of asthma and COPD awareness in Turkey (GARD Turkey Project-National control program of chronic airway diseases)[J]. Tuberk Toraks, 2013, 61(3): 175-182.
5
Jin J, Liu X, Sun Y. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function[J]. Respir Res, 2014, 15: 130.
6
张金蓉,李惠,陈斌. 肺功能检查配合困难患者干预措施的研究[J]. 医学综述,2013, 19(24): 4595-4596.
7
de Miguel Díez J, Jiménez García R, Hernández Barrera V, et al. Trends in Self-Rated Health Status and Health Services Use in COPD Patients (2006-2012). A Spanish Population-Based Survey[J]. Lung, 193(1): 53-62.
8
Zuriarrain Reyna Y, López Neyra A, Sanz Santiago V, et al. Assessing the measurement of airway resistance by the interrupter technique [J]. Arch Argent Pediatr, 2013, 111(6): 495-501.
9
Ramlal SK, Visser FJ, Hop WC, et al. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD[J]. Pulm Pharmacol Ther, 2014, 28(2): 158-164.
10
杨思嘉,刘锦铭,刘盼盼,等. 脉冲振荡肺功能在COPD分级诊断中的应用价值[J]. 山东医药,2011, 51(16): 44-46.
11
蒋国华,江雪红,魏玉萍. 呼吸阻抗测定在慢性阻塞性肺疾病中的应用[J]. 临床肺科杂志,2010, 15(2): 209-210.
12
Komarow HD, Young M, Nelson C, et al. Vocal cord dysfunction as demonstrated by impulse oscillometry[J]. J Allergy Clin Immunol Pract, 2013, 1(4): 387-393.
13
Crim C, Celli B, Edwards LD, et al. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results[J]. Respir Med, 2011, 105(7): 1069-1078.
14
何光辉,黄民强,伍北寿,等. 脉冲震荡肺功能在稳定期COPD治疗中的应用价值[J]. 现代生物医学进展,2016, 16(11): 2099-2101.
15
Abe T, Setoguchi Y, Kono Y, et al. Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study[J]. Pulm Pharmacol Ther, 2011, 24(5): 617-624.
16
张连东,裴新军,谭美春,等. 慢性阻塞性肺疾病急性加重期血清瘦素与肺功能关系的临床研究[J]. 中国急救医学,2014, (8): 708-710.
17
许萍,刘晓静,徐春燕,等. 脉冲振荡技术在支气管哮喘诊断中的临床应用[J]. 重庆医学,2011, 40(1): 7-8.
18
刘长智,郑晓滨,陈超琳,等. 脉冲振荡技术在COPD与支气管哮喘鉴别诊断中的价值[J]. 临床肺科杂志,2013, 18(5): 851-853.
19
李航,蔡金龙,曲书强. 脉冲振荡技术在支气管哮喘治疗效果评价中的临床应用[J]. 临床肺科杂志,2016(1): 119-120.
[1] 周杉京, 诸葛金科, 王芳芳. 补肺活血胶囊对COPD患者cCor、ALD、Ang-Ⅱ的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 517-519.
[2] 吴庆华, 冒勇, 闫效坤. AECOPD并发AKI的危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 529-531.
[3] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[4] 熊锋, 娄建丽. 慢性阻塞性肺疾病急性加重期预后的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 550-553.
[5] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[6] 林静, 陈芳, 刘小霞. COPD患者认知功能障碍影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 569-571.
[7] 张七妹, 麦宜准, 蒋浩波. 喘可治对慢性阻塞性肺疾病缓解期的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 578-580.
[8] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[9] 唐英俊, 李华娟, 王赛妮, 徐旺, 刘峰, 李羲, 郝新宝, 黄华萍. 人脐带间充质干细胞治疗COPD小鼠及机制分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 476-480.
[10] 徐丽玲, 卢玉宝, 赵彦, 任利, 李姝艺, 符娟, 康玲, 汪青松, 尤再春. COPD管理云平台的构建及临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 481-484.
[11] 李海明, 刘鸿飞, 李俊. 血清脂蛋白酶水平与COPD患者骨骼肌质量减少的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 500-503.
[12] 廖玥, 王可, 秦江月, 吴艳秋, 陈俊, 汪涛, 文富强, 王浩. 丹龙口服液治疗轻中度慢性阻塞性肺疾病急性加重期的多中心及前瞻性研究[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 306-311.
[13] 张译梵, 张海华, 王瑛, 高贵洲, 王晓东, 屈林, 张涛. 陕西省成人慢性阻塞性肺疾病危险因素及预测模型[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 312-317.
[14] 宣瑞萍, 刘笑琴, 王平, 查日田. 无创正压通气与经鼻高流量氧疗治疗AECOPD合并Ⅱ型呼吸衰竭的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 346-348.
[15] 刘霞, 何婷媚, 吴映南, 崔文佳. 南通地区非吸烟COPD患者肺癌患病风险及相关影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 367-369.
阅读次数
全文


摘要